Sub menu

Update to listed medicine ingredients in March 2026

Published

Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2026

Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2026, which commenced on 1 March 2026. This determination replaces the previous instrument, the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2025.

This instrument is updated frequently and there may be a more recent version of the instrument. Ensure you are accessing the current version of the instrument through the Therapeutic Goods Determination page.

A complete list of the 22 changed ingredients is below:

Changed ingredients
Substance nameChange
PolyisobutyleneChange
Stannic oxideChange
Calcium hydroxycitrateChange
Garcinia gummi-guttaChange
Garcinia quaesitaChange
Hydroxycitrate complexChange
Hydroxycitric acidChange
Parsley herb dryChange
Parsley herb oilChange
Parsley herb powderChange
Parsley seed oilChange
Petroselinum crispumChange
PhenoxyethanolChange
Potassium hydroxycitrateChange
Rue oilChange
Ruta graveolensChange
Sodium hydroxycitrateChange
Xanthium sibiricumChange
Xanthium strumariumChange
Lauryl methacrylate/sodium methacrylate crosspolymer dispersion (40 per cent)Change
Sorbitan distearateChange
Stearoyl glutamic acidChange
Topics
Featured in

Related content

  • Update to listed medicine ingredients in March 2025

    Regulatory decision notices
    Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2025, which commenced on 1 March 2025

  • Update to listed medicine ingredients in December 2025

    Regulatory decision notices
    Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2025, which commenced on 10 December 2025.